HI
ACAD icon

Horizon Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Horizon Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$950K Buy
37,556
+37,532
+156,383% +$826K 0.01% 750
2026
Q1 		$534 Sell
24
-55,332
-100% -$1.32M ﹤0.01% 1362
2025
Q4 		$1.48M Sell
55,356
-25,616
-32% -$612K 0.02% 541
2025
Q3 		$1.73M Buy
80,972
+49,819
+160% +$1.18M 0.02% 498
2025
Q2 		$672K Buy
+31,153
New +$579K 0.01% 668
2025
Q1 		– Sell
-824
Closed -$15.1K – 862
2024
Q4 		$15.1K Buy
+824
New +$13.3K ﹤0.01% 668

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Horizon Investments's ACAD Position: Q2 2026 in Review

Horizon Investments increased its Acadia Pharmaceuticals (ACAD) stake by 156,383% in Q2 2026, buying an estimated $826K and bringing the position to 37,556 shares worth $950K. The position accounts for 0.01% of the portfolio, ranked #750.

Horizon Investments first reported a position in ACAD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.73M in Q3 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Horizon Investments held 37,556 shares of Acadia Pharmaceuticals worth $950K as of Q2 2026.
  • Horizon Investments bought 37,532 Acadia Pharmaceuticals shares in Q2 2026, an estimated $826K.
  • Acadia Pharmaceuticals made up 0.01% of Horizon Investments's portfolio in Q2 2026, its #750 holding.
  • Horizon Investments first reported a position in Acadia Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Horizon Investments's Acadia Pharmaceuticals position peaked at $1.73M in Q3 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.